Dr. Mustafa Solak adalah seorang dokter onkologi medis dengan keahlian dalam kanker payudara, testis, ovarium, paru-paru, kepala-leher, dan saluran pencernaan. Ia lulus dari Fakultas Kedokteran Universitas Hacettepe. Ia menyelesaikan program residensinya di Rumah Sakit Pengajaran dan Penelitian Istanbul Sisli Etfal. Ia kemudian melanjutkan program fellowship di Institut Kanker Universitas Hacettepe.
Dr. Solak telah menangani banyak kasus kanker yang kompleks. Ia telah berkontribusi pada kemajuan klinis di pusat-pusat terkemuka, termasuk University of Texas MD Anderson Cancer Center. Ia juga pernah bekerja di Rumah Sakit Pelatihan Hitit University Corum dan Rumah Sakit Medical Park. Pengalamannya menunjukkan komitmen yang kuat terhadap perawatan dan penelitian kanker.
Prof. Merimsky mengepalai Unit Onkologi Jaringan Lunak dan Tulang di Sourasky Medical Center, berspesialisasi dalam terapi radiasi presisi tinggi seperti TrueBeam untuk kasus-kasus kompleks.
Dr. Raj Nagarkar is a leading Surgical Oncologist with 19 years of experience. He has performed over 50,000 cancer surgeries. His main focus areas are Breast and Thoracic Surgical Oncology. He is involved in more than 200 clinical trials and has contributed to many national and international publications.
Dr. Nagarkar trained in Surgical Oncology at Tata Memorial Hospital, Mumbai. He also holds an MRCS from the Royal College of Surgeons, Edinburgh. He teaches DNB Superspecialty Surgical Oncology and Breast Surgery at Maharashtra University of Health Sciences. Dr. Nagarkar is dedicated to improving the quality of life for his patients.
Direktur Institut Radioterapi, Divisi Onkologi, di Pusat Medis Sourasky (Ichilov).
Education/Residency:
Dr. Tatyana Rabin's research interests include:
Methods of destruction of malignant neoplasms by heating with the help of ultrasonic waves, research into the use of brachytherapy in the treatment of oncogynecological diseases,
study of the mechanisms of response at the molecular level of prostate tumor cells to radiotherapy;
clinical studies of oncomammology, oncopulmonology, ocular lymphoma.
Dr. Rabin is investigating the molecular mechanisms by which prostate cancer cells respond to radiation therapy. This research is being conducted in collaboration with the Weizmann Institute of Science.
In addition, Dr. Rabin has been involved in clinical research in the areas of breast cancer, lung cancer, and ocular lymphoma.
Dr. Rabin is currently coordinating a new and unique study at Sheba Hospital that is investigating a method of treating cancerous tumors using MRI-guided ultrasound waves. This method involves raising the tumor's temperature to a certain level and then destroying it.
Awards:
Dr. Tatyana Rabin was recognized as the best hospital employee for 2007.
Experience and participation in scientific research:
Membership in medical societies :
Profesor Ari Rafael — direktur layanan Onkologi Translasional dan peneliti di departemen penelitian klinis kanker di Pusat Medis Suraski (Ichilov, Tel Aviv). Pasien menghargai pendekatannya yang individual dan perhatian terhadap kebutuhan setiap individu.
Kualifikasi dan nilai bagi pasien:
Memimpin rumah sakit onkologi siang hari dan mengarahkan proyek-proyek kedokteran genom nasional. Hal ini memastikan akses ke penelitian terkini.
Bekerja sebagai penyelidik sub-utama dan penyelidik utama dalam banyak uji klinis fase I–III, termasuk suntikan intratumoral mRNA dan obat-obatan virus. Pasien mendapatkan kesempatan untuk berpartisipasi dalam metode pengobatan inovatif.
Memiliki pengalaman internasional di AS dan Inggris — menjamin penerapan standar dunia dan protokol canggih.
Anggota organisasi internasional (ESMO, IASLC, ISLB, ISCORT, Asosiasi Medis Israel). Menggunakan standar pengobatan modern dan berpartisipasi dalam penelitian global.
Secara rutin meningkatkan kualifikasi dan mengikuti pelatihan sesuai standar praktik klinis internasional, termasuk ICH GCP R2, Panduan MOH Israel, serta kursus terbaru tentang persetujuan yang diinformasikan, penanganan efek samping, dan keselamatan pasien.
Pasien menghargai Profesor Rafael atas pilihan rencana pengobatan yang tepat, penerapan inovasi, dan perhatian yang mendetail, yang memberikan rasa percaya dan aman pada setiap tahap terapi.
Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.
He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.
Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.
| Dokter | pengalaman | Good Fit For | What Sets Them Apart | Clinic & Location | Consultation |
|---|---|---|---|---|---|
| 41 tahun pengalaman | Kasus sarkoma kompleks | Memimpin unit sarkoma terkemuka di Israel dengan keahlian TrueBeam. Anggota fakultas ESMO untuk kanker tulang/sarkoma dengan pelatihan fellowship di Paris di Institut Gustave Roussy. | Israel | dari $950 | |
| 27 tahun pengalaman | Kasus radioterapi tingkat lanjut | Memimpin Divisi Onkologi Institut Radioterapi, berspesialisasi dalam teknologi TrueBeam untuk pengobatan kanker yang presisi. | Israel | Harga berdasarkan permintaan |